The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2016 | The challenge of drug affordability in multiple myeloma around the world
Keith Stewart
• 3 Jun 2016
Keith Stewart, MB, ChB from the Mayo Clinic, Scottsdale, AZ discusses the issue of drug affordability and access in multiple myeloma (MM). Prof Stewart talks about how it is becoming more of a challenge to get access to novel drugs and how the situation differs between the US and other countries.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
